U.S., April 29 -- ClinicalTrials.gov registry received information related to the study (NCT07554131) titled 'Evaluation of Echothiophate in Pediatric Patients With Refractory Amblyopia' on Feb. 23.
Brief Summary: The goal of this clinical trial is to see if a medicine called echothiophate iodide (Phospholine Iodide) can help treat children with refractory amblyopia. Amblyopia (also called lazy eye) is when one eye doesn't see as well as it should because the brain isn't using that eye correctly. Refractory amblyopia means a lazy eye that's very difficult to treat and it doesn't improve even after using common treatments, such as putting atropine eye drops in the stronger eye to encourage use of the weaker eye.
The main questions this stu...